Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Nancy Ginder, BSN, OCN
CONTACT
Rosemary Stefiniw, RN, MS, CCRC
CONTACT
Lead
Atlantic Health System
With
The primary specific aim of the study is to establish the maximum tolerated dose (MTD) of CPI-613 when given in combination with gemcitabine/nab-paclitaxel for patients with locally advanced or metastatic pancreatic cancer.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted